Value Bridge — YALE NEW HAVEN HOSPITAL
Current $-541M → Target $-465M (+$76.1M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-540.9M
Current EBITDA
$-464.8M
Target EBITDA
+$76.1M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$17.2M
Payer Mix Optimization
$41.3M
Cost to Collect Reduction
$13.8M
Clean Claim Improvement
$10.3M
Volume & Rate Growth
$68.9M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-541M to $-465M. The highest-impact lever is Volume & Rate Growth at $27.6M probability-weighted.
IC talking point: "We see $76M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $838M in equity value creation."